Skip to main content

Smith & Nephew Snats ADR(SNN-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Smith & Nephew Snats ADR

BUILDING 5 CROXLEY PARK HATTERS LANE
WATFORD X0 WD18 8YE GBR
P: 44-19-2347-7340
http://www.smith-nephew.com

Profile

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Key Executives

NameTitle
John Terence RogersCFO/Director
Deepak S. NathCEO/Director
Helen BarracloughGeneral Counsel/Secretary

More from The Globe

opinion
Why are Canadian bank valuations so low?
Tom Bradley
number cruncher
Eleven U.S. semiconductor stocks showing strength
For Number Cruncher column in Globe Investor/ROB only.
Wednesday’s analyst upgrades and downgrades
An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
Bullish on Archer-Daniels-Midland Co.
Monica Rizk
Constellation ‘well-positioned’ to tackle AI disruption in software industry, company president says
In this photo illustration, a mobile phone with the logo of Canadian company Constellation Software Inc. is seen in front of business website.
number cruncher
Eight telecom stocks to watch during volatile times
For Number Cruncher column in Globe Investor/ROB only.
The most oversold and overbought stocks on the TSX
The TMX Market Centre is shown in Toronto, Wednesday, Sept. 11, 2024.
Small caps to watch: Aecon, Maple Leaf Foods, Tecsys and more
Packages of Maple Leaf Foods chicken breasts are shown on a shelf at a grocery store in Oakville, Ont., Friday, Jan.6, 2023.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.